Collaborative work on evaluation of ovarian toxicity 15) Two- or four-week repeated-dose studies and fertility study of bromocriptine in female rats

Journal of Toxicological Sciences

Volumn 34, Issue 1 SPEC. ISS., 2009, Pages

  Kumazawa, Toshihiko ^a   Nakajima, Atsushi ^a   Ishiguro, Tsukasa ^a   Jiuxin, Zhu ^a   Tanaharu, Takashi ^a   Nishitani, Hiromi ^a   Inoue, Yukiko ^a   Harada, Satoko ^a   Hayasaka, Ikuo ^a   Tagawa, Yoshiaki ^a  

^a SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

Author keywords

Bromocriptine mesylate; Female fertility study; Ovarian toxicity; Rats; Repeated dose toxicity study

Indexed keywords

BROMOCRIPTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORPUS LUTEUM; ESTRUS CYCLE; EVALUATION; FEMALE; FEMALE FERTILITY; HISTOPATHOLOGY; MALE; MORPHOLOGY; NONHUMAN; ORGAN WEIGHT; OVARY; PREGNANCY; RAT; REPRODUCTIVE TOXICITY; SEXUAL BEHAVIOR;

ANIMALIA; RATTUS;

EID: 64949171408     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.s157     Document Type: Article

References (14)

1. Beaulieu, M., Goldman, M.E., Miyazaki, K., Frey, E.A., Eskay, R.L., Kebabian, J.W. and Cote, T.E. (1984): Bro- mocriptine-induced changes in the biochemistry, physiology, and histology of the intermediate lobe of the rat pituitary gland. Endocrinology, 114, 1871-1884.
2. Dissaneevate, P. and Warne, G.L. (1998): Hyperprolactinaemia and pituitary adenomas in adolescence. J. Pediatr. Endocrinol. Metab., 11, 531-541.
3. Flückiger, E. and Wagner, H.R. (1968): 2-Br-α-Ergokryptin: Beeinflussung von Fertilitat and Laktation bei der Ratte. Experientia, 24, 1130-1131.
4. Flülckiger, E., Del Pozo, E. and Von Werder, K. (1982): Prolactin. In Physiology, pharmacology and clinical findings., pp.32-37, Springer-Verlag, Berlin.
5. Gaytan, F., Bellido, C., Morales, C. and Sánchez-Criado, J.E. (1998): Both prolactin and progesterone in proestrus are necessary for the induction of apoptosis in the regressing corpus luteum of the rat. Biol. Reprod., 59, 1200-1206.
6. Kauppila, A., Martikainen, H., Puistola, U., Reinilä, M. and Rönnberg, L. (1988): Hypoprolactinemia and ovarian function. Fertil. Steril., 49, 437-441.
7. Kiya, T., Endo, T., Goto, T., Yamamoto, H., Ito, E., Kudo, R. and Behrman, H.R. (1998): Apoptosis and PCNA expression induced by prolactin in structural involution of the rat corpus luteum. J. Endocrinol. Invest., 21, 276-283.
8. Kofler, R., Tabarelli, M., Berger, P. and Wick, G. (1981): In vivo studies on prolactin function in the female rat: Divergent effects of treatment with bromoergocryptine and antisera to rat prolactin. J. Reprod. Immunol., 3, 219-225.
9. Muller, U., Bauknecht, Th. and Siebers, J.W. (1980): The effect of bromocriptine during early pregnancy in the rat: Inhibition of implantation. Acta Endocrinol., 94, 268-272.
10. Richardson, B.P., Turkalj, I. and Fuckiger, E. (1984): Bromocriptine. In Safety Testing of New Drugs. Laboratory Predictions and Clinical Performance. Chap. 3, Laurence, D.R., McLean, A.E.M., Weatherall, M. (eds.), pp.19-63, Academic Press, London.
11. Rothchild, I. (1981): The regulation of the mammalian corpus luteum. Recent Prog. Horm. Res., 37, 183-298.
12. Rothchild, I. (1996): The corpus luteum revisited: Are the paradoxical effects of RU486 a clue to how progesterone stimulates its own secretion? Biol. Reprod., 55, 1-4.
13. Wutke, W. and Meites, J. (1971): Luteolytic role of prolactin during the estrous cycle of the rat. Proc. Soc. Exp. Biol. Med., 137, 988-991.
14. Yamada, T., Ohsawa, K. and Ohno, H. (1988): The usefulness of alkaline solutions for clearing the uterus and staining implantation sites in rats. Jikken Doubutsu, 37, 325-331.